![](/img/cover-not-exists.png)
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis
Charlott Brunmark, Anna Runström, Lennart Ohlsson, Birgitta Sparre, Thomas Brodin, Mikael Åström, Gunnar HedlundVolume:
130
Year:
2002
Language:
english
Pages:
10
DOI:
10.1016/s0165-5728(02)00225-4
File:
PDF, 438 KB
english, 2002